Management of Severe Congenital Blepharoptosis

Evaluation of Polytetrafluoroethylene (Ptose-up) in Management of Severe Congenital Blepharoptosis

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04214379

Enrollment

Registered

2020-01-02

Start date

2017-02-01

Completion date

2018-09-17

Last updated

2020-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blepharoptosis

Brief summary

Frontalis sling surgery was carried out using Ptose-up under general anaesthesia for patients with severe congenital ptosis.

Detailed description

Frontalis sling surgery was carried out using Ptose-up for patients with severe congenital ptosis in 23 eyes of 15 patients and they followed up for at least 6 months to detect the success rate and if there is any postoperative complications.

Interventions

PROCEDUREPtosis surgery

Frontalis sling surgery using pose-up and Wright's fascia-lata needle

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

11 Months to 9 Years

Healthy volunteers

Inclusion criteria

* Severe congenital blepharoptosis * Poor levator muscle function * No previous ptosis surgery

Exclusion criteria

* Patients with Jaw winking phenomenon * Blepharophimosis syndrome * Congenital myasthenia

Design outcomes

Primary

Measure	Time frame	Description
Improvement of ptosis	3 months	The average marginal reflex distance was improved from -0.8 mm preoperative to +2.73 mm after 3 months

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026